1. Managing Dual Regulatory Frameworks and SEC Disclosures
Foreign private issuers entering US markets face concurrent oversight from the Securities and Exchange Commission and home-country securities authorities.
SEC Registration and Home-Country Regulatory Harmonization
Foreign private issuers preparing for US public offerings under Form F-1 or Form 20-F must align applicable home-country disclosures with federal securities regulations. Reconciling ongoing reporting obligations involves managing material disclosures, applicable foreign exchange filings, and parallel shareholder communications. Securing legal guidance in capital markets ensures compliance across jurisdictions while mitigating SEC enforcement exposure.
Pre-Listing Corporate Governance Alignment
Establishing US-compliant corporate governance prior to registration requires reviewing board independence, audit committees, and executive compensation disclosures under applicable Exchange Act rules. Companies operating through shell structures or carve-out transactions must review inter-company contracts, transfer pricing agreements, and tax implications under Internal Revenue Service standards to prevent post-listing shareholder disputes.
2. Assessing CFIUS Screening and National Security Risk
International issuers involving critical technology, sensitive personal data, or critical infrastructure may face CFIUS review in connection with certain foreign investments or SPAC transactions.
FIRRMA Regulations and Mandatory Declarations
Under the Foreign Investment Risk Review Modernization Act (FIRRMA), the Committee on Foreign Investment in the United States (CFIUS) reviews certain foreign investments involving US businesses that qualify as TID US businesses based on critical technology, critical infrastructure, or sensitive personal data. Issuers based in foreign jurisdictions must evaluate whether a covered transaction requires a mandatory declaration or whether a voluntary notice is appropriate to address potential national security concerns. Engaging a firm experienced in CFIUS compliance allows issuers to evaluate and structure pre-listing transactions with applicable national security requirements in mind.
Anti-Corruption Audits and Vendor Base Vetting
Foreign private issuers that qualify as issuers under the FCPA may be subject to the Foreign Corrupt Practices Act (FCPA) anti-bribery and accounting provisions. Legal due diligence should review third-party vendors, foreign sales agents, and government interactions in home markets to identify potential bribery risks. Establishing robust anti-bribery protocols and consulting experienced attorneys in government and internal investigations ensures compliance across global operations and supply chains.
The table below outlines primary regulatory triggers and corresponding due diligence strategies during cross-border offerings:
| Regulatory Area | Core Federal Requirement | Risk Mitigation Strategy |
|---|---|---|
| CFIUS Review | Mandatory declaration for certain covered TID investments | Evaluate filing requirements before SEC registration |
| FCPA Audit | 15 U.S.C. § 78dd-1 anti-bribery compliance | Screen third-party intermediaries and vendor contracts |
| Accounting Standard | Reconciliation of IFRS to US GAAP reporting | Audit working capital schedules and ASC 606 standards |
CFIUS Review
- Core Federal RequirementMandatory declaration for certain covered TID investments
- Risk Mitigation StrategyEvaluate filing requirements before SEC registration
FCPA Audit
- Core Federal Requirement15 U.S.C. § 78dd-1 anti-bribery compliance
- Risk Mitigation StrategyScreen third-party intermediaries and vendor contracts
Accounting Standard
- Core Federal RequirementReconciliation of IFRS to US GAAP reporting
- Risk Mitigation StrategyAudit working capital schedules and ASC 606 standards
3. Reconciling Accounting Standards and Managing Complex Transactions
Cross-border offerings often involve complex corporate restructuring, SPAC business combinations, or accounting standard reconciliations.
IFRS to US GAAP Conversion Red Flags
Mid-transaction conversions from International Financial Reporting Standards (IFRS) to US GAAP may reveal revenue recognition differences under ASC 606 versus IFRS 15. Financial restatements affect working capital calculations, representations and warranties, and indemnification caps in transaction agreements. Working with attorneys skilled in international transactions helps structure transaction agreements to accommodate accounting adjustments and mitigate post-closing disputes.
Hostile Bids and SPAC Cross-Border Mechanics
Foreign acquirers and SPAC parties may need to address SEC Schedule 13D, Schedule 14D, registration, proxy, or other filing requirements while coordinating with foreign competition law reviews. In cross-border De-SPAC transactions, earnout structures denominated in foreign currencies require foreign exchange hedging mechanisms and clear contractual enforcement terms to protect investor value.
4. Frequently Asked Questions
How does CFIUS oversight affect a foreign private issuer listing on a US stock exchange?
CFIUS evaluates certain foreign investments in US businesses and covered real estate transactions for national security concerns. If an issuer is involved in a TID US business, particular foreign investments may be subject to CFIUS review or mandatory declaration requirements depending on the transaction structure and applicable regulations.
What are the main challenges when converting foreign accounting standards to US GAAP during an IPO?
Converting from IFRS or foreign GAAP to US GAAP can alter reported revenue, working capital, and earnings before interest and taxes, depending on the applicable accounting requirements. Discrepancies in revenue recognition under ASC 606 versus IFRS 15 can affect transaction valuations and representation and warranty insurance terms.
5. Schedule a Cross-Border IPO Compliance Consultation
If your organization is preparing for a US public listing, SPAC merger, or cross-border transaction, securing proactive legal guidance is essential. Contact our legal team today to schedule a confidential strategy session with an attorney.
10 Aug, 2026
